Advances in Viral Infections
Viruses cause a wide range of human diseases, from the common cold and influenza to hepatitis, measles and encephalitis. Research on how viruses work is leading to better tests, treatments and vaccines.
The Advances in Viral Infections session at Infectious 2027 covers progress across viral diseases. It connects closely with COVID 19 and other coronaviruses, which focuses on one of the most studied virus families.
Viruses cause many of the most common infections, from colds to influenza. Some, such as hepatitis viruses, can cause long-term illness. Unlike bacteria, viruses cannot be treated with antibiotics. Vaccines and antiviral medicines are the main tools against them.
Key Topics in Advances in Viral Infections
• Influenza and respiratory viruses
• RSV and human metapneumovirus
• Viral hepatitis
• Herpesviruses and CMV
• Measles and other vaccine-preventable viruses
• Viral encephalitis
• New antiviral drugs
• Monoclonal antibodies for viral infections
• Viral evolution and resistance
• Host–virus interactions
Recent Advances in Advances in Viral Infections
New antivirals for influenza, hepatitis and CMV are improving outcomes, and long-acting antibodies are preventing RSV in infants. Research on viral evolution and host response draws on molecular biology and genomics.
Rapid multiplex tests from diagnostic innovations in infectious diseases identify several viruses at once. High-impact outbreaks are covered in Ebola, Zika, and other viral infections.
Long-acting antibodies are now protecting infants and vulnerable adults from some viruses. New antivirals are improving treatment for influenza and hepatitis. Researchers are working on vaccines that protect against many strains at once. Better understanding of the immune response is guiding treatment choices.
Who Should Attend the Advances in Viral Infections Session
• Virologists and infectious disease physicians
• Immunologists
• Antiviral and vaccine researchers
• Clinical laboratory scientists
• PhD students and early-career researchers
• Pharma and biotech teams
Why Present Your Research in Advances in Viral Infections
Presenting at Infectious 2027 lets you share viral research with clinicians and scientists worldwide. You can connect with colleagues in vaccine development and immunization working on viral vaccines. Virology moves fast, and new findings appear often. Presenting here helps share your results with the clinicians who can use them.
Frequently Asked Questions
Can I present influenza research?
Yes. Influenza and other respiratory viruses are key topics.
Does this session cover antiviral drug development?
Yes. New antivirals and antibodies are welcome topics.
Where is Infectious 2027?
Infectious 2027 is held at Village Hotel Changi, Singapore, from 11 to 13 March 2027, with online participation.